MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-CH-01-0019859
Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals Private Limited - chemicals in Chandigarh, India. Directors, charges & compliance details.
Revenue · FY 2024
₹56.75 Lakh
▲ 283% YoY
Net profit · FY 2024
₹81,310
Net margin 1.4%
EBITDA · FY 2024
₹1.13 Lakh
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Beecan Pharmaceuticals Private Limited
Data last updated:
Beecan Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 09 September 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24110CH2022PTC044602.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harshit Agarwal and Magan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO – 832 Cabin No.7 2nd Floor Nac Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹56.75 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹81,310 (net margin 1.4%) and EBITDA of ₹1.13 Lakh (EBITDA margin 2%).
Beecan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0019859).
Company Details of Beecan Pharmaceuticals Private Limited
CIN U24110CH2022PTC044602
Registration Number 044602
Incorporation Date 09 September 2022
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0019859
Key People
Harshit Agarwal Director Magan Singh Director Recognitions & Rankings of Beecan Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSCO – 832 Cabin No.7 2nd Floor Nac Manimajra, Chandigarh, India – 160101
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
Comprehensive company report
Beecan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Beecan Pharmaceuticals Private Limited
The main business activity of Beecan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Beecan Pharmaceuticals Private Limited FY 2025 filings available
Beecan Pharmaceuticals Private Limited reported revenue of ₹56.75 Lakh (up 283% YoY) for FY 2024.
Revenue · FY 2024
₹56.75 Lakh ▲ 283%
Net profit · FY 2024
₹81,310 margin 1.4%
EBITDA · FY 2024
₹1.13 Lakh margin 2%
Compounded Annual Growth Rate (CAGR) of Beecan Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 283%
EBITDA CAGR growth
1 year
▲ 701%
Revenue rose 283% in the latest year. EBITDA rose 701% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Beecan Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹1.13 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹81,310 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Beecan Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2% | •••• |
| Net Profit Margin | 1.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Beecan Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshit Agarwal | Director | 09 Sep 2022 | 4 Years 1 Months | Current |
| Magan Singh | Director | 09 Sep 2022 | 4 Years 1 Months | Current |
Peer Comparison of Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Egzeon Pharmaceuticals Private Limited | ₹57.23 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Ambala Cantt, Haryana, India |
| Novostar Pharmaceuticals Private Limited | ₹57.22 Lakh (FY 2025) | •••• | •••• | 119.0% | •••• | Ambala, Haryana, India |
| Capricon Pharmaceuticals Private Limited | ₹57.19 Lakh (FY 2018) | •••• | •••• | -59.0% | •••• | New Delhi, Delhi, India |
| Ms Bio Pharmaceuticals Private Limited | ₹57.16 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| La Mantus Pharmaceuticals Private Limited | ₹56.97 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | New Delhi, Delhi, India |
| Beecan Pharmaceuticals Private Limited this company | ₹56.75 Lakh (FY 2024) | •••• | •••• | 283.0% | •••• | Chandigarh, India |
| Clarianz Pharmaceuticals Private Limited | ₹56.53 Lakh (FY 2022) | •••• | •••• | -12.0% | •••• | Latur, Maharashtra, India |
| Medimaster Pharmaceuticals Private Limited | ₹56.17 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Motihari, Bihar, India |
| Vithai Pharmaceuticals Private Limited | ₹56.12 Lakh (FY 2024) | •••• | •••• | 173.0% | •••• | Mumbai, Maharashtra, India |
| Michaels Pharmaceuticals Private Limited | ₹56.08 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | New Delhi, Delhi, India |
| Criswell Pharmaceuticals Private Limited | ₹55.99 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Beecan Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Beecan Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Beecan Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Harshit Agarwal was appointed as Director on 09 Sep 2022.
AGM
Beecan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Beecan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Harshit Agarwal was appointed as Director.
Appointed
Magan Singh was appointed as Director.
Incorporation
09 Sep 2022
Beecan Pharmaceuticals Private Limited was registered on 09 Sep 2022 with Roc Chandigarh & aged 4 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Beecan Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Beecan Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Beecan Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Beecan Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Beecan Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beecan Pharmaceuticals Private Limited
Beecan Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 09 September 2022 (4+ years old) and is registered under CIN U24110CH2022PTC044602.
Beecan Pharmaceuticals reported revenue of ₹56.75 Lakh for FY 2024 (up 283% YoY).
Beecan Pharmaceuticals has 2 current directors:
- Harshit Agarwal - Director
- Magan Singh - Director
Beecan Pharmaceuticals reported a net profit of ₹81,310 (net margin 1.4%) and EBITDA of ₹1.13 Lakh (EBITDA margin 2%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Beecan Pharmaceuticals is U24110CH2022PTC044602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Beecan Pharmaceuticals was incorporated on 09 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Beecan Pharmaceuticals by revenue are Egzeon Pharmaceuticals Private Limited, Novostar Pharmaceuticals Private Limited, Capricon Pharmaceuticals Private Limited, Ms Bio Pharmaceuticals Private Limited, La Mantus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Harshit Agarwal was appointed as Director on 09 Sep 2022. Magan Singh was appointed as Director on 09 Sep 2022.
Yes, Beecan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0019859).
The registered office of Beecan Pharmaceuticals is at SCO – 832 Cabin No.7 2nd Floor Nac Manimajra, Chandigarh, India – 160101.
Beecan Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.